NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
Back to search
Official data from USPTO
GLYCOPATH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GLYCOPATH
ST13
US500000097895631Class
1, 5, 42
Filing
97895631
Registration
7603978
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
12/17/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
04/19/2023
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
12/17/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/09/2021
First use in commerce
11/09/2021
Drawing code
4
Owner type
16
Owner location
BILLERICA, MA
Examiner
RINGLE, JIM
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BRUKER SCIENTIFIC LLC
GlycoPath, Inc.
Representatives
Trevor P. Schmidt HUTCHISON PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents and assays for scientific and research use
Class 5
Medical diagnostic reagents and assays for testing body fluids; diagnostic biomarker reagents for medical purposes; biological and biochemical diagnostic preparations for medical purposes; Medical diagnostic kit consisting primarily of medical reagents and assays for collecting and testing of blood to identify biomarkers relevant to cancermetabolic diseases and aging
Class 42
Research and development in the field of biomarkers and clinical assay development; medical and scientific research in the field of biological testinginterpretationdiagnosis of diseases; consulting services in the field of biochemical assay design; custom design and development of chemical reagents and biochemical assays; consulting services in the field of biotechnologythe investigation and analysis of biomarkers and assay development for the medical diagnostic services industry
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2024
PUBO
PUBLISHED FOR OPPOSITION
09/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/24/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/24/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/24/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/24/2024
GNRT
NON-FINAL ACTION E-MAILED
01/24/2024
CNRT
NON-FINAL ACTION WRITTEN
01/24/2024
DOCK
ASSIGNED TO EXAMINER
01/17/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/15/2023
NWAP
NEW APPLICATION ENTERED
04/22/2023
Continuous trademark protection
Get notified about every new filing that threatens GLYCOPATH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.